Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid syndrome: review.

Lisa R Sammaritano1

  • 1Weill Medical College of Cornell University, Hospital of Special Surgery, New York, NY 10021, USA. sammaritan@hss.edu

Southern Medical Journal
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Biologic Disease-Modifying Antirheumatic Drug Use During Pregnancy and Lactation.

Obstetrics and gynecology·2026
Same author

Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

ACR open rheumatology·2025
Same author

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Arthritis care & research·2025
Same author

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.

Arthritis care & research·2025
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Antiphospholipid syndrome involves antibodies and complications like blood clots or pregnancy loss. Treatment typically uses anticoagulation, but optimal intensity and duration remain under discussion.

Area of Science:

  • Internal Medicine
  • Rheumatology
  • Hematology

Background:

  • Antiphospholipid syndrome (APS) is a multisystem disorder.
  • Diagnostic criteria involve antiphospholipid antibodies and clinical events such as thrombosis or pregnancy morbidity.
  • Associated conditions include livedo reticularis, thrombocytopenia, and organ damage.

Purpose of the Study:

  • To review the clinical manifestations and diagnostic criteria of Antiphospholipid Syndrome.
  • To discuss current treatment strategies for APS complications.
  • To highlight areas of ongoing debate in APS management.

Main Methods:

  • Literature review of Antiphospholipid Syndrome.
  • Analysis of diagnostic criteria and clinical associations.

Related Experiment Videos

  • Summary of established and evolving treatment protocols.

    • Main Results:

    • APS is characterized by specific antibodies and a spectrum of clinical events.
    • Common manifestations include thrombosis, pregnancy loss, thrombocytopenia, and organ-specific damage.
    • Anticoagulation is the cornerstone of management for thrombotic events and pregnancy.

    Conclusions:

    • Antiphospholipid syndrome requires multidisciplinary management.
    • Current treatments focus on anticoagulation, with ongoing research into optimal therapeutic strategies.
    • Further research is needed to refine anticoagulation protocols and address management controversies.